Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
Edina Cenko, Lina Badimón, Raffaele Bugiardini, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 14, pp. 2705-2729
Open Access | Times Cited: 127
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity
Miriam Sindelar, Ethan Stancliffe, Michaela Schwaiger-Haber, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 8, pp. 100369-100369
Open Access | Times Cited: 103
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Julia Maret Hermens, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 295-307
Open Access | Times Cited: 42
Contribution of STAT3 to the pathogenesis of COVID-19
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 81
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
Zijing Guo, Zhidong Zhang, Meera Prajapati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1876-1876
Open Access | Times Cited: 80
Therapeutic potential of ginger against COVID-19: Is there enough evidence?
Abdollah Jafarzadeh, Sara Jafarzadeh, Maryam Nemati
Journal of Traditional Chinese Medical Sciences (2021) Vol. 8, Iss. 4, pp. 267-279
Open Access | Times Cited: 74
Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country
Essamedin M. Negm, Mohamed Sorour Mohamed, Rehab Ahmed Rabie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101508-101508
Open Access | Times Cited: 52
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107763-107763
Open Access | Times Cited: 49
Lymphopenia in Covid-19: A single center retrospective study of 589 cases
El Aidouni Ghizlane, Manal Merbouh, E. Abderrahim, et al.
Annals of Medicine and Surgery (2021) Vol. 69
Open Access | Times Cited: 47
Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence
Filippos Filippatos, Elizabeth‐Barbara Tatsi, Athanasios Michos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5711-5711
Open Access | Times Cited: 18
Temporary Molecular Relapse of Myeloid Leukemias in the Setting of COVID-19 and Viral-Induced Immunosuppression
Ishan Bhatia, Lloyd Hutchinson, Jan Černý
LabMed (2025) Vol. 2, Iss. 1, pp. 2-2
Open Access
Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia
Gusti Harti, Syifa Nur Maulida, Evan Susandi, et al.
Journal of Blood Medicine (2025) Vol. Volume 16, pp. 61-74
Open Access
Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons
Abdollah Jafarzadeh, Maryam Nemati, Bhaskar Saha, et al.
Viral Immunology (2020) Vol. 34, Iss. 5, pp. 307-320
Closed Access | Times Cited: 40
Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain
Sergi Cantenys-Molina, Eduardo Fernández‐Cruz, P Francos, et al.
Clinical & Experimental Immunology (2020) Vol. 203, Iss. 3, pp. 424-432
Open Access | Times Cited: 39
Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
Catia Cillóniz, Héctor José Peroni, Albert Gabarrús, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 39
Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection
Xin Wang, Gang Xu, Xiaoju Liu, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2313-2324
Open Access | Times Cited: 37
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study
Maurin Lampart, Núria Zellweger, Stefano Bassetti, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0269005-e0269005
Open Access | Times Cited: 26
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
Yikan Sun, Can Wang, Peiquan Lin, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 4, pp. 307-324
Open Access | Times Cited: 4
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation
Enrique Alfaro, Elena Díaz‐García, Sara García-Tovar, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 442-442
Open Access | Times Cited: 20
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós, et al.
Cytotherapy (2023) Vol. 26, Iss. 1, pp. 25-35
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top